Psoriasis treatments may impact bone health, new study finds
NCT ID NCT07140666
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study looked at 100 adults with moderate-to-severe psoriasis to see how two common biologic drugs, Secukinumab and Adalimumab, affect bone density. Researchers measured bone mineral density in the spine and hip over time. The goal was to understand if these treatments help or harm bone health, since psoriasis itself may raise the risk of osteoporosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Secukinumab and Adalimumab
What this could lead to
If successful, this could help doctors choose psoriasis treatments that also protect bone health, reducing the risk of osteoporosis.
What could go wrong
This is a small, completed observational study, not a treatment trial. Results may not apply to all patients, and it does not test a new drug or cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chinese PLA General Hosptial
Beijing, Beijing Municipality, 100853, China